glimepiride 3 MG Oral Tablet
glimepiride
RxCUI: 153842
What the CMS Formulary Data Shows for glimepiride 3 MG Oral Tablet
Per the CMS 2026 Part D formulary file, glimepiride 3 MG Oral Tablet (RxNorm concept RXCUI 153842, generic name glimepiride) appears on 6 distinct formulary files spanning 14 Medicare Part D plan offerings - 0.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 1.8.
Real-world access to glimepiride 3 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 16.7% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,187,344 Part D beneficiaries filled glimepiride 3 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $62,964,614 and an average per-beneficiary annual cost of $53.03. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry glimepiride 3 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 6
- Plans covering
- 14
- Coverage rate
- 0.3%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 16.7% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,187,344
- Total spending
- $62,964,614
- Avg per beneficiary
- $53.03
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering glimepiride 3 MG Oral Tablet
14 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Mass General Brigham Advantage (PPO) | Mass General Brigham Health Plan, Inc. | T1 | No | $0 | MA |
| Mass General Brigham SCO (HMO D-SNP) | MASS GENERAL BRIGHAM HEALTH PLAN, INC | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | MASS GENERAL BRIGHAM HEALTH PLAN, INC | T1 | No | $0 | MA |
| Leon MediExtra (HMO) | LEON HEALTH, INC. | T1 | No | $0 | FL |
| Leon MediDual (HMO D-SNP) | LEON HEALTH, INC. | T1 | No | $0 | FL |
| Leon MediMore (HMO) | LEON HEALTH, INC. | T1 | No | $0 | FL |
| Leon MediMax (HMO D-SNP) | LEON HEALTH, INC. | T1 | No | $0 | FL |
| Mass General Brigham Advantage Secure (HMO-POS) | Mass General Brigham Health Plan, Inc. | T1 | No | $62.00 | MA |
| Mass General Brigham Advantage Premier (PPO) | Mass General Brigham Health Plan, Inc. | T1 | No | $79.70 | MA |
| Mass General Brigham Advantage Signature (PPO) | Mass General Brigham Health Plan, Inc. | T1 | No | $147.20 | MA |
| Aspire Health Protect (HMO) | ASPIRE HEALTH PLAN | T6 | No | $0 | CA |
| Aspire Health Value (HMO) | ASPIRE HEALTH PLAN | T6 | No | $22.60 | CA |
| Aspire Health Advantage (HMO) | ASPIRE HEALTH PLAN | T6 | No | $44.80 | CA |
| Aspire Health Plus (HMO-POS) | ASPIRE HEALTH PLAN | T6 | No | $119.20 | CA |
Frequently Asked Questions
Is glimepiride 3 MG Oral Tablet covered by Medicare Part D?
Yes, glimepiride 3 MG Oral Tablet is covered by 14 Medicare Part D plans (0.3% of all Part D formularies).
What tier is glimepiride 3 MG Oral Tablet on Medicare Part D plans?
glimepiride 3 MG Oral Tablet averages Tier 1.8 across Part D plans, ranging from Tier 1 to Tier 6.
Does glimepiride 3 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for glimepiride 3 MG Oral Tablet. Step therapy: 0%. Quantity limits: 16.7%.
How much does Medicare spend on glimepiride 3 MG Oral Tablet?
In 2023, total Medicare Part D spending on glimepiride 3 MG Oral Tablet was $62,964,614, covering 1,187,344 beneficiaries. The average spend per beneficiary was $53.03.
Read our methodology - how this data is sourced, computed, and verified.